Windtree Therapeutics Inc

WINT

Exchange: OTC
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0000946486

SEC filings (opens in a new tab)

No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Windtree Therapeutics Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of WINT: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	9	12	+3
Shares	2.57K	121.1K	+118.5K (+4,609.1%)
Value	$12.8K	$151.7K	+$138.9K (+1,081.9%)

New holders (4)

Institutions that held Windtree Therapeutics Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to WINT in Q2 2023
Institution	Shares	Value	% of portfolio
Virtu Financial LLC	42,667	$54.0K	0.00%
Acadian Asset Management LLC	31,583	$39.0K	0.00%
Citadel Advisors LLC	21,722	$27.3K	0.00%
Two Sigma Securities, LLC	16,871	$21.1K	0.00%

Sold out (1)

Institutions that held Windtree Therapeutics Inc at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of WINT in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Gradient Investments LLC	1	$5